Provided by Tiger Trade Technology Pte. Ltd.

Annovis Bio, Inc.

1.82
+0.06503.71%
Volume:26.52K
Turnover:47.64K
Market Cap:77.21M
PE:-1.01
High:1.82
Open:1.76
Low:1.76
Close:1.75
52wk High:5.50
52wk Low:1.54
Shares:42.54M
Float Shares:35.32M
Volume Ratio:0.55
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7895
EPS(LYR):-1.4040
ROE:-703.68%
ROA:-142.36%
PB:-18.15
PE(LYR):-1.29

Loading ...

Annovis Bio Reaches Full Enrollment in Phase 3 Early Alzheimer’s Trial of Buntanetap

Reuters
·
Jul 07

Annovis Bio - Symptomatic Data Readout Expected Q1 2027, Disease-modifying Data Readout Expected Q1 2028

THOMSON REUTERS
·
Jul 07

Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease

THOMSON REUTERS
·
Jul 07

Annovis Bio - Preparing for Two Nda Submissions Following Data Readouts

THOMSON REUTERS
·
Jul 07

Press Release: Annovis Appoints Cheng Fang, Ph.d., as Chief Scientific Officer

Dow Jones
·
Jul 01

Annovis Bio Shareholders Approve Governance and Compensation Changes

TIPRANKS
·
Jun 18

Annovis Bio shareholders approve 2019 equity plan share increase to 5.5 million

Reuters
·
Jun 18

Annovis Bio: Buy Rating Reiterated as Late-Stage Neurodegenerative Pipeline Advances; $8 Price Target Unchanged

TIPRANKS
·
May 29

Annovis Bio Regains Nyse Listing Compliance

THOMSON REUTERS
·
May 26

Annovis Bio Regains NYSE Listing Compliance

GlobeNewswire
·
May 26

Annovis Bio director Michael B Hoffman buys $141,027 of common shares

Reuters
·
May 22

Annovis Bio Announces Dilutive Equity Offering for Trials

TIPRANKS
·
May 21

BRIEF-Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants

Reuters
·
May 20

Annovis Bio 7.9M share Spot Secondary priced at $1.90

TIPRANKS
·
May 20

Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants

THOMSON REUTERS
·
May 20

Annovis Bio Inc - Combined Offering Price per Share and Warrant Is $1.90

THOMSON REUTERS
·
May 20

Annovis Bio announces common stock and warrants offering, no amount given

TIPRANKS
·
May 20

Annovis Bio launches underwritten public offering of common stock with warrants

Reuters
·
May 20

Annovis Bio Inc - Proceeds to Fund Phase 3 Buntanetap Development and General Purposes

THOMSON REUTERS
·
May 20

Press Release: Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants

Dow Jones
·
May 20